JPM US Growth X (dist) USD |
Performance History | 31/03/2024 |
Growth of 1,000 (EUR) |
Fund | - | - | - | - | 18.3 | |
+/-Cat | - | - | - | - | 5.1 | |
+/-Idx | - | - | - | - | 4.2 | |
Category: US Large-Cap Growth Equity | ||||||
Benchmarks: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 23/04/2024 | USD 121.89 | |
Day Change | 0.93% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
ISIN | LU0626448426 | |
Fund Size (Mil) 23/04/2024 | USD 3279.62 | |
Share Class Size (Mil) 23/04/2024 | USD 50.68 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2016 | 0.15% |
Investment Objective: JPM US Growth X (dist) USD |
To provide long-term capital growth by investing primarily in a growth style biased portfolio of US companies. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Giri Devulapally 20/12/2010 | ||
Joseph Wilson 17/02/2017 | ||
Inception Date 23/05/2011 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 Growth NR USD | Morningstar US LM Brd Growth NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM US Growth X (dist) USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 9.59 |
NVIDIA Corp | Technology | 7.87 |
Amazon.com Inc | Consumer Cyclical | 7.11 |
Meta Platforms Inc Class A | Communication Services | 6.14 |
Eli Lilly and Co | Healthcare | 5.40 |
Increase Decrease New since last portfolio | ||
JPM US Growth X (dist) USD |